Tower Hematology Oncology Medical Group — Los Angeles, California

Tower Hematology Oncology Medical Group is a clinical research site located in Los Angeles, California, United States 90048.

Crixeo Health Trust Score: 76/100 (FAIR). This profile has not yet been claimed by the site owner.

Tower Hematology Oncology Medical Group has participated in 10 clinical trials.

Therapeutic areas: Lymphoma, Low-Grade, Mantle Cell Lymphoma, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.

Sponsors: Favrille, Spectrum Pharmaceuticals, Inc, Chiron Corporation.

Sponsor Feasibility Report

Trust Score: 76/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Tower Hematology Oncology Medical Group?

Tower Hematology Oncology Medical Group has a Crixeo Trust Score of 76/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Tower Hematology Oncology Medical Group conducted?

Tower Hematology Oncology Medical Group has 10 clinical trials on record. Their work covers Lymphoma, Low-Grade, Mantle Cell Lymphoma, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.

Is Tower Hematology Oncology Medical Group accredited by Crixeo Health?

Yes — Tower Hematology Oncology Medical Group holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Tower Hematology Oncology Medical Group?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.